| Kelly Graves, MD | |
|
135 Rutledge Ave, Charleston, SC 29425-8903 | |
| (843) 876-0888 | |
| Not Available |
| Full Name | Kelly Graves |
|---|---|
| Gender | Female |
| Speciality | Geriatric Medicine |
| Experience | 7 Years |
| Location | 135 Rutledge Ave, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417480245 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 86558 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Musc Health At Home, By Bayada- Charleston | Charleston, SC | Home health agency |
| Musc Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
CT colonography allows radiologists to predict, with a high degree of confidence, whether or not a polyp needs to be evaluated through colonoscopy or removed through polypectomy, according to a study performed at the University of Wisconsin School of Medicine and Public Health in Madison, WI.
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has successfully completed a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the proposed Phase III clinical study for COL-003, the Company's tamper-resistant, extended release oxycodone product utilizing its proprietary DETERx technology.
AIDS Healthcare Foundation has chastised Abbott Laboratories for its 'quid pro quo' offer to the Government of Thailand to lower its price for Abbott's key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$800 per patient per year - an offer contingent upon Abbott's demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.
Women who give birth to infants with congenital heart defects may have an increased risk of cardiovascular hospitalizations later in life, according to new research in the American Heart Association's journal Circulation.
› Verified 9 days ago
| Entity Name | University Medical Associates Of The Medical University Of South Carol |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
CT colonography allows radiologists to predict, with a high degree of confidence, whether or not a polyp needs to be evaluated through colonoscopy or removed through polypectomy, according to a study performed at the University of Wisconsin School of Medicine and Public Health in Madison, WI.
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has successfully completed a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the proposed Phase III clinical study for COL-003, the Company's tamper-resistant, extended release oxycodone product utilizing its proprietary DETERx technology.
AIDS Healthcare Foundation has chastised Abbott Laboratories for its 'quid pro quo' offer to the Government of Thailand to lower its price for Abbott's key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$800 per patient per year - an offer contingent upon Abbott's demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.
Women who give birth to infants with congenital heart defects may have an increased risk of cardiovascular hospitalizations later in life, according to new research in the American Heart Association's journal Circulation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Graves, MD Po Box 751461, Charlotte, NC 28275-1461 Ph: (843) 792-6200 | Kelly Graves, MD 135 Rutledge Ave, Charleston, SC 29425-8903 Ph: (843) 876-0888 |
News Archive
CT colonography allows radiologists to predict, with a high degree of confidence, whether or not a polyp needs to be evaluated through colonoscopy or removed through polypectomy, according to a study performed at the University of Wisconsin School of Medicine and Public Health in Madison, WI.
Scientists at the Wyss Institute for Biologically Inspired Engineering at Harvard University have devised a better assay for testing blood's clotting tendency, also known as hemostasis, which could one day prove lifesaving in a variety of clinical situations in which a patient's health is jeopardized by abnormal blood coagulation and platelet function.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced today that it has successfully completed a Type A meeting with the U.S. Food and Drug Administration (FDA) regarding the proposed Phase III clinical study for COL-003, the Company's tamper-resistant, extended release oxycodone product utilizing its proprietary DETERx technology.
AIDS Healthcare Foundation has chastised Abbott Laboratories for its 'quid pro quo' offer to the Government of Thailand to lower its price for Abbott's key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$800 per patient per year - an offer contingent upon Abbott's demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.
Women who give birth to infants with congenital heart defects may have an increased risk of cardiovascular hospitalizations later in life, according to new research in the American Heart Association's journal Circulation.
› Verified 9 days ago
Dr. Jeffrey Peter Yourshaw, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-876-4807 Fax: 843-876-4809 | |
Jennifer Lee Martin, D.O. Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Nikko Rowe Asuncion Tabliago, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Moses K Asempah, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 717-491-3745 | |
Paige Nicole Laverick, PA-C Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Amit Agrawal, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Yevgeniy Gelfand, MD Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-0111 |